Agronomics Limited

AIM-ANIC
London Stock Exchange AIM
Financials Asset Management
Global Rank
#24584
Country Rank
#631
Market Cap
97.26 M
Price
9.63
Change (%)
4.70%
Volume
2.56 M

Agronomics Limited's latest marketcap:

97.26 M

As of 06/14/2025, Agronomics Limited's market capitalization has reached $97.26 M. According to our data, Agronomics Limited is the 24584th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 97.26 M
Revenue (ttm) -19,921,007.7
Net Income (ttm) -23,214,556.15
Shares Out 1.01 B
EPS (ttm) -0.02
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date n/a
Market Cap Chart
Data Updated: 06/14/2025

Agronomics Limited's yearly market capitalization.

Agronomics Limited has seen its market value grow from £59.92 M to £97.26 M since 2020, representing a total increase of 62.30% and an annual compound growth rate (CAGR) of 11.49%.
Date Market Cap Change (%) Global Rank
06/14/2025 £97.26 M 92.26% 24584
12/31/2024 £39.11 M -58.67% 28129
12/29/2023 £94.65 M -17.9% 21875
12/30/2022 £115.28 M -45.38% 20195
12/31/2021 £211.05 M 252.21% 16774
12/31/2020 £59.92 M 21750

Company Profile

Investment Focus

Agronomics Limited is a private equity and venture capital firm specializing in investments across various stages, including:

  • Emerging growth
  • Seed/startup
  • Early venture
  • Series B
  • Growth capital

Investment Strategy

The firm invests in both quoted and unquoted companies, with a preference for:

  • Alternative proteins and cellular agriculture
  • Cultivated meat and related technologies
  • Modern foods and materials industries
  • Biopharma and biotechnology sectors

It primarily makes minority investments in portfolio companies and may also invest in biopharma sector debt (up to 15% of net asset value).

Additional Investment Activities

The firm may also allocate capital to:

  • Collective investment schemes with biopharma exposure
  • Long-term equity anticipation securities tied to biopharma sectors

Funding Approach

Agronomics typically invests from its balance sheet capital, rather than raising external funds.

Company Background

Founded on May 3, 2011, Agronomics Limited is headquartered in Ramsey, Isle of Man.

Frequently Asked Questions

  • What is Agronomics Limited's (AIM-ANIC) current market cap?
    As of 06/14/2025, Agronomics Limited (including the parent company, if applicable) has an estimated market capitalization of $97.26 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Agronomics Limited global market capitalization ranking is approximately 24584 as of 06/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.